Sen-Jam Pharmaceutical Joins Forces with The Global Passion Project for Transformative Healthcare Summit in Palm Beach

HUNTINGTON, N.Y., April 1, 2025 /PRNewswire/ -- Sen-Jam Pharmaceutical is proud to sponsor and participate in The Global Passion Project's upcoming Healthcare Investor Summit, taking place April 8–9, 2025, in Palm Beach, Florida. This exclusive, invitation-only event brings together some of the world's most influential investors, visionary biotech founders, and purpose-driven health leaders to reimagine the future of healthcare.

Uniting bold ideas and real-world solutions, the summit features two immersive days of curated networking, yacht-based introductions, and high-impact panels on longevity, metabolics, mental health, diagnostics, creativity in medicine, and artificial intelligence. Among the featured speakers are trailblazers like:

• Jackie Iversen, RPh MS, Co-Founder and Chief Clinical Officer of Sen-Jam Pharmaceutical, joining the Metabolic Disorders & Longevity panel on April 9
  
  
• An executive from NVIDIA, and Jack Hidary, former Google executive and current CEO of Sandbox AQ, leading AI innovation with Silicon Valley's brightest discussing the transformative role of AI in health transformation
  
  
• Dave Asprey, renowned biohacker and wellness futurist, sharing insights on peak human performance
  
  

Sen-Jam Pharmaceutical's inclusion as a core sponsor underscores its rapid rise as one of the most exciting players in the global pharmaceutical innovation space. With its patented PAIR (Pleiotropic Anti-Inflammatory Regulator) platform, Sen-Jam is transforming the way the world addresses inflammation—not by suppressing symptoms, but by working in harmony with the body's innate systems to reduce inflammatory response at the source. Their proactive, rather than reactive, approach holds promise across a wide array of indications, from viral infections to alcohol hangover to opioid withdrawal recovery.

"Sen-Jam operates at the intersection of evidenced-based science, humanity, and transformation," said Christine Leonard, Director of Strategic Communications at Sen-Jam. "We're proud to support a gathering that invites big thinking and meaningful collaboration. The Global Passion Project Summit is exactly the kind of high-trust, visionary environment where the next era of healthcare gets shaped."

This collaboration highlights a shared belief in the power of purpose, people, and possibility.

"The Global Passion Project exists to unite the best minds and boldest hearts for impact," said Andrea Bartzen, Founder of The Global Passion Project. "Sen-Jam is a unicorn in the making—evidence-based, future-forward, and deeply mission-driven. We're thrilled to spotlight them at this year's summit."

Members of the press and investment community who are interested in attending may request credentials or more information via the following link:

Request Press or Investor Access: contact [email protected]

About Sen-Jam Pharmaceutical

Sen-Jam Pharmaceutical is on a mission to transform inflammatory care around the world. Its pioneering PAIR Technology platform modulates inflammation at the source through a dual-mechanism approach, unlocking safer, faster-acting, and longer-lasting therapies that preserve vitality and promote well-being. From hangover prevention to respiratory relief and opioid withdrawal treatment, Sen-Jam is reshaping what's possible across multiple indications. Learn more at www.sen-jam.com.

About The Global Passion Project

The Global Passion Project is a visionary initiative founded to create a platform where passionate leaders, entrepreneurs, investors, and changemakers converge to co-create the future. Through high-touch experiences, curated summits, and dynamic thought leadership, TGPP builds bridges between bold ideas and real-world solutions to address humanity's most pressing health challenges. Learn more at www.globalpassionprojects.com.

CONTACT INFORMATION:
Sen-Jam Pharmaceutical
Christine Leonard
[email protected]
781-913-1902

SOURCE Sen-Jam Pharmaceutical